GlassScriptPhysician profile
Clarissa Ko
NPI 1538706460
$2,448.06
in general payments reported to CMS, 2019-2025
9 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.37 · 2022: $114 · 2023: $724 · 2024: $560 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $1,248.10 | 2023-2025 | Trinav Infusion System |
| Medtronic, INC. | $660.27 | 2023-2025 | Osteocool Rf Ablation System, Emprint, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $314.77 | 2025 | Penumbra System, Ruby Coil, Indigo System |
| Terumo Medical Corporation | $113.91 | 2022 | |
| B. Braun Interventional Systems INC. | $28.37 | 2021 | |
| Teleflex LLC | $25.22 | 2023 | Arrow |
| Davol INC. | $23.79 | 2025 | Venovo |
| Avanos Medical | $20.76 | 2025 | Coolief Cooled Radiofrequency |
| Bard Peripheral Vascular, INC. | $12.87 | 2023 | Bard Marquee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarissa Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.